Overview

Therapeutic Efficacy of "Abroma Agusta" in HbA1c % in NIDDM

Status:
Available

Trial end date:
2014-12-01

Target enrollment:
0

Participant gender:
All

Summary

Objective: To ascertain whether homoeopathic medicine ABROMA AUGUSTA has a clinical role in changing the Glycated Hb Level in Diabetes mellitus Type II. Abstract: Background: Type 2 diabetes mellitus (T2DM) is one of the most important epidemic diseases in the world in this century, and accounts for 90% of cases of diabetes globally. Studies have suggested that Abroma Augusta plays a role in acute controlling blood glucose level. The aim of this study was to evaluate the efficacy of "Abroma Augusta Ѳ" in chronic control through GlycatedHb (HbA1c %) in Diabetes Mellitus Type 2 (NIDDM) as a pretest post-test study.

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Fr Muller Homoeopathic Medical College

Criteria

Inclusion Criteria:

Inclusion Criteria Age 30 Years above Both Sexes NIDDM FBS - 110-300mg/dl HbA1c above ≤ 6.5

-

Exclusion Criteria:

- Patient with major complications like diabetic retinopathy and cardiomyopathy. IDDM
HbA1c above 11%